Advancing Peritoneal Dialysis (PD)
Millions of patients worldwide depend on dialysis to survive.
Our novel fluid, PDprotec®, is designed
to improve the outcomes of this treatment and
reduce the burden of kidney failure for patients and health care providers.
PDprotec® addresses the global market for
PD-fluids (USD 3 billion) and has the potential to increase the share of PD in the overall dialysis market (USD 13 billion)
PDprotec® – key advantages
Improved clinical outcome
Prolonged time for which patients can benefit from PD
Increase market share of PD in dialysis overall
The Zytoprotec success story
> read more
- Product prepared to enter pivotal Phase III trial in 2021
- Outstanding safety and efficacy demonstrated for PDprotec® in Phase I/II and Phase II studies
- Orphan Drug designation granted by FDA
- Follow-on PD fluid ICOprotec™ ready for clinical development
Science and Technology
The development of PDprotec® has been advanced by Zytoprotec’s own scientists and clinical experts and by the expertise and support provided by global leaders in the field of PD represented in our Scientific Advisory Board.
Scientific Advisory Board
Global Medical Lead, Orphan Renal Diseases, Vifor Pharma, Switzerland
General Hospital Vienna, Austria
University Hospital of North Staffordshire, UK
University Hospital Saint-Luc, Brussels, Belgium
Medical Clinic I, Cologne, Germany
University Hospital La Princesa, Madrid, Spain
Harborview Medical Center and Kidney Research Institute, University of Washington Seattle, USA
Arbor Research, Ann Arbor (MI), USA
St Michael’s Hospital and University of Toronto, Canada
University Hospital, Heidelberg
The Chinese University, Hong Kong
University of Colorado Hospital, Aurora (CO), USA
University of Medicine, Cardiff, UK
University Medical Center, Amsterdam, NL
Sheffield Teaching Hospitals, UK
Poznan University of Medical Sciences, Poznan, Poland
A clear step forward in next generation PD solutions.
Prof. Dr. Nicholas Topley
They say a bit of stress is good for you – Zytoprotec research shows nicely how you can incorporate this principle into clinical practice of PD.
Prof. Dr. Janusz Witowski
An attractive approach to preserve the peritoneal membrane.
Prof. Dr. Manuel Lopez Cabrera